Article
The role of the blood-brain barrier during pneumococcal meningitis
2016-01-01
Abstract excerpt
Background: Pneumococcal meningitis remains the main cause of severe bacterial meningitis in children and adults (1); in February, 2010, a new 13-valent pneumococcal conjugate vaccine (PCV13) was approved by the FDA, which was presented as a successor to the 7-valent conjugate vaccine (PCV7) (2). Nonetheless, no vaccine provides protection against more than 90 serotypes of Streptococcus pneumoniae. In 2013, 2.8 mi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 57b8160b-bd04-5575-ae7d-2a29d84d967d
- DOI
- 10.17638/03000478
